Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 11.22 CAD 1.08%
Market Cap: 4.1B CAD
Have any thoughts about
Bausch Health Companies Inc?
Write Note

Bausch Health Companies Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bausch Health Companies Inc
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Bausch Health Companies Inc
TSX:BHC
PP&E Net
$1.8B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
3%
Sundial Growers Inc
NASDAQ:SNDL
PP&E Net
CA$282.6m
CAGR 3-Years
34%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
PP&E Net
$38m
CAGR 3-Years
-43%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
PP&E Net
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
PP&E Net
CA$21.6m
CAGR 3-Years
-8%
CAGR 5-Years
66%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
PP&E Net
$836m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Bausch Health Companies Inc
Glance View

Market Cap
4.1B CAD
Industry
Pharmaceuticals

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. The company is headquartered in Laval, Quebec and currently employs 19,600 full-time employees. The firm is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in over 100 countries. Its segments include Bausch + Lomb, Salix, Ortho Dermatologics, International Rx and Diversified Products. The Bausch + Lomb segment consists of sales in the United States of Bausch + Lomb Vision Care, Consumer, Surgical and Ophthalmology Rx products. The Salix segment consists of sales in the United States of gastroenterology (GI) products. The Ortho Dermatologics segment consists of sales in the United States of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices.

BHC Intrinsic Value
114.17 CAD
Undervaluation 90%
Intrinsic Value
Price

See Also

What is Bausch Health Companies Inc's PP&E Net?
PP&E Net
1.8B USD

Based on the financial report for Sep 30, 2024, Bausch Health Companies Inc's PP&E Net amounts to 1.8B USD.

What is Bausch Health Companies Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
3%

Over the last year, the PP&E Net growth was 13%. The average annual PP&E Net growth rates for Bausch Health Companies Inc have been 4% over the past three years , 2% over the past five years , and 3% over the past ten years .

Back to Top